Clinical Trial Update: Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating dexamfetamine sulfate for severe asthenia in glioma patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Dexamfetamine Sulphate (dexamfetamine sulfate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Glioma | Phase 3 | Status: UNKNOWN